✦ LIBER ✦

Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis

✍ Scribed by Rougier, Ph.; Ducreux, M.; Mahjoubi, M.; Pignon, J.P.; Bellefqih, S.; Oliveira, J.; Bognel, C.; Lasser, Ph.; Ychou, M.; Elias, D.

Book ID: 123234345
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 853 KB
Volume: 30
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(94)90170-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant chemotherapy in locally adva

Neoadjuvant chemotherapy in locally advanced gastric carcinoma—a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum

✍ Rougier, Ph; Mahjoubi, M; Lasser, Ph; Ducreux, M; Oliveira, J; Ychou, M; Pignon, 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 935 KB

Phase II trial of sorafenib in combinati

Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma

✍ Iacopo Petrini; Monica Lencioni; Miriam Ricasoli; Mauro Iannopollo; Cinzia Orlan 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 261 KB

A phase II trial of 5-fluorouracil, doxo

A phase II trial of 5-fluorouracil, doxorubicin, mitomycin C, and leucovorin in advanced gastric carcinoma

✍ Susan G. Arbuck; Yusuf Silk Md; Harold O. Douglass Jr.; Hector Nava; Youcef M. R 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 2 views

To determine the feasibility and toxicity of combining leucovorin (CF) with a 5fluorouracil(5-FU) combination chemotherapy regimen currently accepted by many as standard treatment for gastric cancer, CF (500 mg/m') was administered in combination with the Georgetown S-FU, doxorubicin, and mitomycin

Phase II trials of 5-fluorouracil and le

Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma

✍ Joseph Rubin; James G. Gallagher; Georgene Schroeder; Allan J. Schutt; Robert J. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 3 views

Conducted as a collaborative trial of North Central Cancer Treatment Group and Mayo Clinic.

Phase II study of protracted infusional

Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: Report from the Japan Clinical Oncology Group (JCOG)

✍ Ohtsu, A.; Shimada, Y.; Yoshida, S.; Saito, H.; Seki, S.; Morise, K.; Kurihara, 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 369 KB

A phase II trial of interferon alpha-2A,

A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma

✍ David H. Ilson; Matthew Sirott; Leonard Saltz; Robert Heelan; Ying Huang; Roger 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 574 KB